Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Protein expression within oncogenic or suppressive pathways is a hallmark indicator of oncogenesis. While traditional AI models in digital pathology attempt to predict singular proteins, there is a need to predict the downstream expression of proteins to indicate the propagation of signals. RNA expression provides novel information, but does not provide information about the downstream propagation...
The understanding of how transcriptional programs give rise to cellular morphology, and how morphological features reflect and influence cell identity and function remains limited. This is due in part to the lack of large-scale datasets pairing the two modalities as well as the absence of computational frameworks capable of modeling their cross-modal structure. Here, we introduce COSMIC, a bidirec...
Chronic wounds affect over 1.2 million Canadians and incur healthcare costs exceeding $13 billion annually, with global expenditures approaching $149 ...
Glycosphingolipids (GSLs) are essential components of biological membranes with important roles in cell signalling. Disrupted GSL metabolism is associ...
Accurate prediction of mutational dependencies to model tumor evolution can improve our understanding of cancer progression and is crucial for early d...
Understanding and engineering T-cell receptor (TCR) specificity is central to personalized immunotherapy and antigen discovery. However, while antigen...
We propose a reliable and energy-efficient framework for 3D brain tumor segmentation using spiking neural networks (SNNs). A multi-view ensemble of sa...
Deep learning models in computational pathology often fail to generalize across cohorts and institutions due to domain shift. Existing approaches eith...
B-cell maturation antigen (BCMA) shedding by {gamma}-secretase generates soluble BCMA (sBCMA) , which diminishes membrane antigen density, and limits ...
Selection of systemic therapy for breast cancer remains largely empirical, particularly for chemotherapy, due to the lack of robust biomarkers that pr...
Despite a decade of immunotherapy, treatment selection in non-small cell lung cancer (NSCLC) still relies on subgroup analyses and clinical scores. I3...
Cervical intraepithelial neoplasia grade 2 (CIN2) lesions show variable outcomes, and accurate prediction of regression remains a major clinical chall...
The successful adaptation of foundation models to multi-modal medical imaging is a critical yet unresolved challenge. Existing models often struggle t...
Contrast medium plays a pivotal role in radiological imaging, as it amplifies lesion conspicuity and improves detection for the diagnosis of tumor-rel...
Early achievement of deep remission improves patients' outcome in chronic myeloid leukemia (CML) treatment, highlighting the need for predictive indic...
Somatic mutations accumulate with cell division and are key to understanding tumor evolution. While single-cell RNA sequencing (scRNA-seq) can effecti...
Supervised deep learning models often achieve excellent performance within their training distribution but struggle to generalize beyond it. In cancer...
Deep learning models for brain tumor analysis require large and diverse datasets that are often siloed across healthcare institutions due to privacy r...
Understanding the role of tertiary lymphoid structures (TLS) is crucial in non-small cell lung cancer (NSCLC), as they are associated with patient pro...
AI agents promise to empower biomedical discovery, but realizing this promise requires the ability to complete transparent, long-horizon analyses usin...